{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:30:51Z","timestamp":1780356651380,"version":"3.54.1"},"reference-count":224,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","award":["NPRP12S-0310\u2013190276"],"award-info":[{"award-number":["NPRP12S-0310\u2013190276"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1175134"],"award-info":[{"award-number":["1175134"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000392"],"award-info":[{"award-number":["82000392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUERG-CMED-2020-2"],"award-info":[{"award-number":["QUERG-CMED-2020-2"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007458","name":"Qatar Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.cbi.2021.109738","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T03:58:26Z","timestamp":1635911906000},"page":"109738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin\u2013angiotensin-aldosterone system (RAAS) dysregulation"],"prefix":"10.1016","volume":"351","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-8392","authenticated-orcid":false,"given":"Robin","family":"Augustine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilash","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajisha","family":"Nayeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheen Abdul","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Maureira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Mraiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-3035","authenticated-orcid":false,"given":"Philip M.","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"McClements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwarul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2021.109738_bib1","first-page":"e35","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami","year":"2020","journal-title":"Arch. Acad. Emerg. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008729","article-title":"Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection","volume":"5","author":"Yoshikawa","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2021.109738_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00554","article-title":"Can stem cells beat COVID-19: advancing stem cells and extracellular vesicles toward mainstream medicine for lung injuries associated with SARS-CoV-2 infections","volume":"8","author":"Chrzanowski","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.cbi.2021.109738_bib4","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2021.109738_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2021.109738_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109738_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/135965350701200S01.1","article-title":"Human coronaviruses: what do they cause?","volume":"12","author":"Van Der Hoek","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.cbi.2021.109738_bib9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(19)33221-0","article-title":"Middle East respiratory syndrome","volume":"395","author":"Memish","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109738_bib10","unstructured":"Coronavirus Disease (COVID-19), (n.d.)."},{"key":"10.1016\/j.cbi.2021.109738_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/dyaa033","article-title":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","volume":"49","author":"Peeri","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.cbi.2021.109738_bib12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","volume":"326","author":"Wong","year":"2003","journal-title":"Br. Med. J."},{"key":"10.1016\/j.cbi.2021.109738_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","volume":"200","author":"Ding","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.cbi.2021.109738_bib15","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/pgmj.2004.030049","article-title":"Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome","volume":"81","author":"Ng","year":"2005","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.thromres.2007.12.021","article-title":"Thrombopoietin levels increased in patients with severe acute respiratory syndrome","volume":"122","author":"Yang","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cbi.2021.109738_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0196-0644(03)00817-5","article-title":"Predictive model of diagnosing probable cases of severe acute respiratory syndrome in febrile patients with exposure risk","volume":"43","author":"Chen","year":"2004","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/00313020310001619118","article-title":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)","volume":"35","author":"Lang","year":"2003","journal-title":"Pathology"},{"key":"10.1016\/j.cbi.2021.109738_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJMc031468","article-title":"SARS in Hong Kong [2]","volume":"349","author":"Wu","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.cbi.2021.109738_bib21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00415-004-0519-8","article-title":"Original communication","volume":"251","author":"Umapathi","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.cbi.2021.109738_bib22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/thorax.58.8.686","article-title":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","volume":"58","author":"Chan","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.cbi.2021.109738_bib23","doi-asserted-by":"crossref","DOI":"10.1046\/j.1440-1843.2003.00522.x","article-title":"SARS: prognosis, outcome and sequelae","volume":"8","author":"Chan","year":"2003","journal-title":"Respirology"},{"key":"10.1016\/j.cbi.2021.109738_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4933-11-4","article-title":"Severe acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses","volume":"11","author":"Clay","year":"2014","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.cbi.2021.109738_bib25","doi-asserted-by":"crossref","DOI":"10.47102\/annals-acadmedsg.V35N5p326","article-title":"SARS in Singapore - predictors of disease severity","volume":"35","author":"Leong","year":"2006","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.cbi.2021.109738_bib26","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1001\/jama.289.21.JOC30885","article-title":"Clinical features and short-term outcomes of 144 patients with SARS in the greater toronto area","volume":"289","author":"Booth","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2021.109738_bib27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"Wang","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijid.2004.04.015","article-title":"SARS in Taiwan: an overview and lessons learned","volume":"9","author":"Chen","year":"2005","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib29","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa030634","article-title":"Identification of severe acute respiratory syndrome in Canada","volume":"348","author":"Poutanen","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib30","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa030666","article-title":"A cluster of cases of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Tsang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cid\/ciu226","article-title":"Middle east respiratory syndrome coronavirus: a case-control study of hospitalized patients","volume":"59","author":"Al-Tawfiq","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12250-015-3679-z","article-title":"Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia","volume":"31","author":"Banik","year":"2016","journal-title":"Virol. Sin."},{"key":"10.1016\/j.cbi.2021.109738_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.21101\/cejph.a4764","article-title":"Mortality rate of ICU patients with the middle east respiratory syndrome \u2013 coronavirus infection at king Fahad hospital, Jeddah, Saudi Arabia","volume":"26","author":"Garout","year":"2018","journal-title":"Cent. Eur. J. Publ. Health"},{"key":"10.1016\/j.cbi.2021.109738_bib36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","volume":"5","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cbi.2021.109738_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-016-1234-4","article-title":"Critically ill patients with Middle East respiratory syndrome coronavirus infection","volume":"20","author":"Al-Dorzi","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.cbi.2021.109738_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","article-title":"Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus","volume":"36","author":"Alhogbani","year":"2016","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.cbi.2021.109738_bib39","first-page":"1260","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science 84"},{"key":"10.1016\/j.cbi.2021.109738_bib40","series-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","author":"Zou","year":"2020"},{"key":"10.1016\/j.cbi.2021.109738_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with middle east respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/resp.13196","article-title":"MERS, SARS and other coronaviruses as causes of pneumonia","volume":"23","author":"Yin","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.cbi.2021.109738_bib43","series-title":"WHO | WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS)","year":"2015"},{"key":"10.1016\/j.cbi.2021.109738_bib44","first-page":"4956","article-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics","volume":"22","author":"Nassar","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2021.109738_bib45","series-title":"Worldometer Coronavirus Live Update","first-page":"1","author":"Worldometer","year":"2021"},{"key":"10.1016\/j.cbi.2021.109738_bib46","series-title":"PERSPECTIVE 692 A Novel Coronavirus Emerging in China A Novel Coronavirus Emerging in China-Key Questions for Impact Assessment","author":"Munster","year":"2020"},{"key":"10.1016\/j.cbi.2021.109738_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016812","article-title":"Prevalence of cardiovascular comorbidities in coronavirus disease 2019, severe acute respiratory syndrome, and Middle East respiratory syndrome: pooled analysis of published data","volume":"9","author":"Liu","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cbi.2021.109738_bib49","article-title":"Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in shanghai, China, MedRxiv prepr","author":"Cao","year":"2020","journal-title":"Serv. Heal. Sci."},{"key":"10.1016\/j.cbi.2021.109738_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1726-4901(09)70124-8","article-title":"Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome","volume":"68","author":"Chen","year":"2005","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.cbi.2021.109738_bib51","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-139-9-200311040-00005","article-title":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","volume":"139","author":"Choi","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.290.3.374","article-title":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome","volume":"290","author":"Lew","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2021.109738_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-016-1303-8","article-title":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients","volume":"20","author":"Almekhlafi","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.cbi.2021.109738_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1492-4","article-title":"Treatment outcomes for patients with middle eastern respiratory syndrome coronavirus (MERS CoV) infection at a coronavirus referral center in the kingdom of Saudi arabia","volume":"16","author":"Al Ghamdi","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejcdt.2015.11.011","article-title":"Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients, Egypt","volume":"65","author":"Halim","year":"2016","journal-title":"J. Chest Dis. Tuberc."},{"key":"10.1016\/j.cbi.2021.109738_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235653","article-title":"Rate of intensive care unit admission and outcomes among patients with coronavirus: a systematic review and Meta-analysis","volume":"15","author":"Abate","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2021.109738_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-02957-9","article-title":"COVID-19 mortality and ICU admission: the Italian experience","volume":"24","author":"Immovilli","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.cbi.2021.109738_bib58","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.CIR.0000094737.21775.32","article-title":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-Day echocardiographic follow-up study","volume":"108","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2021.109738_bib59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","article-title":"Cardiovascular complications of severe acute respiratory syndrome","volume":"82","author":"Yu","year":"2006","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5858\/2004-128-195-AODDTS","article-title":"Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore challenges in determining a SARS diagnosis","volume":"128","author":"Yoon Chong","year":"2004","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.cbi.2021.109738_bib61","series-title":"MERS transmission and risk factors: a systematic review","author":"Park","year":"2020"},{"key":"10.1016\/j.cbi.2021.109738_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-016-3881-4","article-title":"Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis","volume":"16","author":"Matsuyama","year":"2016","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.cbi.2021.109738_bib63","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 \u2014 COVID-NET, 14 states, march 1\u201330, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.cbi.2021.109738_bib64","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/heartjnl-2020-317056","article-title":"Cardiovascular manifestations and treatment considerations in COVID-19","volume":"106","author":"Kang","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.cbi.2021.109738_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.46234\/ccdcw2020.032","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) \u2014 China, 2020","volume":"2","author":"Cdc Weekly","year":"2020","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.cbi.2021.109738_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243191","article-title":"Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: a comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients","volume":"15","author":"Dorjee","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2021.109738_bib67","article-title":"Characteristics and associations with severity in COVID-19 patients: a multicentre cohort study from Jiangsu province, China, SSRN electron","author":"Liu","year":"2020","journal-title":"J"},{"key":"10.1016\/j.cbi.2021.109738_bib68","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of soluble angiotensin-converting enzyme 2 in heart failure. Insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system","volume":"52","author":"Epelman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2021.109738_bib69","article-title":"Association of angiotensin-converting enzyme inhibitors and angiotensin II blockers with severity of COVID-19: a multicenter, prospective study","author":"Hakeam","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"key":"10.1016\/j.cbi.2021.109738_bib70","article-title":"Hypertension, medications, and risk of severe COVID-19: a Massachusetts community-based observational study","author":"Bauer","year":"2020","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.cbi.2021.109738_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105951","article-title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives","volume":"55","author":"Li","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.cbi.2021.109738_bib72","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109738_bib73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","article-title":"ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome","volume":"53","author":"Devaux","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.cbi.2021.109738_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2021.05.001","article-title":"Molecular simulation studies of the interactions between the human\/pangolin\/cat\/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein","volume":"187","author":"Ma","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.cbi.2021.109738_bib75","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109738_bib76","article-title":"Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2","volume":"118","author":"Liu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2021.109738_bib77","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109738_bib78","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcimb.2020.00317","article-title":"ACE2, much more than Just a receptor for SARS-COV-2","volume":"10","author":"Samavati","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cbi.2021.109738_bib79","first-page":"1444","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Renhong","year":"2020","journal-title":"Science 84"},{"key":"10.1016\/j.cbi.2021.109738_bib80","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.cbi.2021.109738_bib81","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry Depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2021.109738_bib82","article-title":"Counter-regulatory \u2018renin-angiotensin\u2019 system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients","author":"Annweiler","year":"2020","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.cbi.2021.109738_bib83","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts","author":"Gallagher","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cbi.2021.109738_bib84","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1113\/expphysiol.2007.040139","article-title":"Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts","volume":"93","author":"Guy","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.cbi.2021.109738_bib85","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00331.2008","article-title":"Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis","volume":"295","author":"Lovren","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cbi.2021.109738_bib86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","article-title":"The role of ACE2 in cardiovascular physiology","volume":"13","author":"Oudit","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib87","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/molmed.2009.00160","article-title":"ACE2 activation promotes antithrombotic activity","volume":"16","author":"Fraga-Silva","year":"2010","journal-title":"Mol. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biochi.2020.04.008","article-title":"Renin-angiotensin system at the heart of COVID-19 pandemic","volume":"174","author":"Alifano","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.cbi.2021.109738_bib90","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cbi.2021.109738_bib91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11886-020-01292-3","article-title":"Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response","volume":"22","author":"Zhu","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.cbi.2021.109738_bib92","first-page":"1","article-title":"Mechanisms of heart failure with preserved ejection fraction in the presence of diabetes mellitus","volume":"3","author":"Lazar","year":"2020","journal-title":"Transl. Metab. Syndr. Res."},{"key":"10.1016\/j.cbi.2021.109738_bib93","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2021756","article-title":"Multisystem inflammatory syndrome in children in New York state","author":"Dufort","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib94","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. Children and adolescents","author":"Feldstein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","author":"Consiglio","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2021.109738_bib96","series-title":"Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management","article-title":"Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection","author":"Nakra","year":"2020"},{"key":"10.1016\/j.cbi.2021.109738_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eclinm.2020.100527","article-title":"Multisystem inflammatory syndrome in children: a systematic review","volume":"26","author":"Ahmed","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cbi.2021.109738_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2020.05.117","article-title":"Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C)","author":"Greene","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib99","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2021.109738_bib100","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000002809","article-title":"Pediatric crohn disease and multisystem inflammatory syndrome in children (MIS-C) and COVID-19 treated with infliximab","author":"Dolinger","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.cbi.2021.109738_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2020.06.045","article-title":"Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York city","author":"Kaushik","year":"2020","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cbi.2021.109738_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-1054-6","article-title":"Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection","author":"Carter","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib103","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.dsx.2020.03.013","article-title":"Cardiovascular disease and COVID-19","volume":"14","author":"Bansal","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.cbi.2021.109738_bib104","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40256-020-00420-2","article-title":"COVID-19 pandemic: cardiovascular complications and future implications","volume":"20","author":"Bandyopadhyay","year":"2020","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.cbi.2021.109738_bib105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.mjafi.2020.05.004","article-title":"Cardiovascular comorbidities and complications associated with coronavirus disease 2019","volume":"76","author":"Mahajan","year":"2020","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.cbi.2021.109738_bib106","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","year":"2020","journal-title":"Zhonghua Liuxingbingxue Zazhi"},{"key":"10.1016\/j.cbi.2021.109738_bib107","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2021.109738_bib108","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19 - navigating the uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib109","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of covid-19 in New York city","volume":"382","author":"Goyal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.cbi.2021.109738_bib111","first-page":"2020","article-title":"Clinical characteristics of coronavirus pneumonia 2019 (COVID-19): an updated systematic review","author":"Fang","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cbi.2021.109738_bib112","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib113","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cbi.2021.109738_bib114","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib115","series-title":"SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart","author":"Dhakal","year":"2020"},{"key":"10.1016\/j.cbi.2021.109738_bib116","first-page":"1077","article-title":"The association of cardiovascular diseases and diabetes mellitus with COVID-19 (SARS-CoV-2) and their possible mechanisms, SN compr","volume":"2","author":"Roy","year":"2020","journal-title":"Clin. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib117","author":"American Heart Association"},{"key":"10.1016\/j.cbi.2021.109738_bib118","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib119","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/eurheartj\/ehaa231","article-title":"Coronaviruses and the cardiovascular system: acute and long-term implications","volume":"41","author":"Xiong","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2021.109738_bib120","article-title":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin","author":"Hu","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2021.109738_bib121","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cbi.2021.109738_bib122","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cbi.2021.109738_bib123","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109738_bib124","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jmv.25809","article-title":"Analysis of heart injury laboratory parameters in 273 COVID\u201019 patients in one hospital in Wuhan, China","volume":"92","author":"Han","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cbi.2021.109738_bib125","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/CIRCULATIONAHA.120.047164","article-title":"The variety of cardiovascular presentations of COVID-19","volume":"141","author":"Fried","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2021.109738_bib126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA statement addresses concerns Re: using RAAS antagonists in COVID-19","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.cbi.2021.109738_bib127","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.jacc.2019.10.049","article-title":"Chimeric antigen receptor T-cell therapy for cancer and heart: JACC Council perspectives","volume":"74","author":"Ganatra","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2021.109738_bib128","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2021.109738_bib129","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109738_bib130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jchf.2020.03.004","article-title":"COVID-19 illness and heart failure: a missing link?","volume":"8","author":"Mehra","year":"2020","journal-title":"JACC Hear. Fail."},{"issue":"17","key":"10.1016\/j.cbi.2021.109738_bib131","first-page":"46","article-title":"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19","volume":"171","author":"Perico","year":"2020","journal-title":"Nat. Rev. Nephrol. 2020"},{"key":"10.1016\/j.cbi.2021.109738_bib132","doi-asserted-by":"crossref","first-page":"104362","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.cbi.2021.109738_bib133","unstructured":"Disseminated Intravascular Coagulation in COVID-19\u2014Insights from the Front Lines | AACC.org, (n.d.)."},{"key":"10.1016\/j.cbi.2021.109738_bib134","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/d41586-020-01403-8","article-title":"Coronavirus blood-clot mystery intensifies","volume":"581","author":"Willyard","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109738_bib135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2021.109738_bib136","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1055\/s-0040-1712097","article-title":"Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?","volume":"120","author":"Cattaneo","year":"2020","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.cbi.2021.109738_bib137","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.cbi.2021.109738_bib138","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109738_bib139","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/micc.12120","article-title":"Roles of coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosis","volume":"21","author":"Senchenkova","year":"2014","journal-title":"Microcirculation"},{"key":"10.1016\/j.cbi.2021.109738_bib140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2021.109738_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biology9080182","article-title":"Loop-mediated isothermal amplification (LAMP): a rapid, sensitive, specific, and cost-effective point-of-care test for coronaviruses in the context of COVID-19 pandemic","volume":"9","author":"Augustine","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.cbi.2021.109738_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9103372","article-title":"Rapid antibody-based covid-19 mass surveillance: relevance, challenges, and prospects in a pandemic and post-pandemic world","volume":"9","author":"Augustine","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib143","first-page":"121704","article-title":"Rapid diagnostics of coronavirus disease 2019 in early stages using nanobiosensors: challenges and opportunities","author":"Sharifi","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.cbi.2021.109738_bib145","doi-asserted-by":"crossref","first-page":"15511","DOI":"10.1128\/JVI.79.24.15511-15524.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs","volume":"79","author":"Sims","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cbi.2021.109738_bib146","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41422-020-0364-z","article-title":"Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques","volume":"30","author":"Shan","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cbi.2021.109738_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118102","article-title":"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions","volume":"257","author":"Jafarzadeh","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2021.109738_bib148","article-title":"Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain","author":"Li","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib149","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41574-020-0353-9","article-title":"Endocrine and metabolic link to coronavirus infection","volume":"16","author":"Bornstein","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cbi.2021.109738_bib150","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1007\/s00018-004-4222-9","article-title":"Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus","volume":"61","author":"Cinatl","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2021.109738_bib151","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2021.109738_bib152","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","author":"Hikmet","year":"2020","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.cbi.2021.109738_bib153","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2009.e26","article-title":"TRPC1 expression and distribution in rat hearts","author":"Huang","year":"2009","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.cbi.2021.109738_bib154","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2021.109738_bib155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.cbi.2021.109738_bib156","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cbi.2021.109738_bib157","doi-asserted-by":"crossref","DOI":"10.2174\/0929867324666170414162841","article-title":"Circulating ACE2 in cardiovascular and kidney diseases","author":"Anguiano","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109738_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2004.03.154","article-title":"The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain","author":"Surjit","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2021.109738_bib159","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2021.109738_bib160","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00109-014-1149-y","article-title":"Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease","volume":"92","author":"Wang","year":"2014","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib161","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016219","article-title":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infec","volume":"9","author":"Guo","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cbi.2021.109738_bib162","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109738_bib163","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2021.109738_bib164","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1113\/expphysiol.2007.040386","article-title":"Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression","volume":"93","author":"Burchill","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.cbi.2021.109738_bib165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.drudis.2010.02.003","article-title":"Angiotensin-converting enzymes and drug discovery in cardiovascular diseases","volume":"15","author":"Shi","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cbi.2021.109738_bib166","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cbi.2021.109738_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102907","article-title":"SARS-CoV-2 and ACE2: the biology and clinical data settling the ARB and ACEI controversy","volume":"58","author":"Chung","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cbi.2021.109738_bib168","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijid.2020.04.027","article-title":"Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection","volume":"96","author":"Zhang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib169","first-page":"1","article-title":"A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin","author":"Hasan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.cbi.2021.109738_bib170","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109738_bib171","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2021.109738_bib172","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib173","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/eurheartj\/ehaa311","article-title":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","volume":"41","author":"Nicin","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2021.109738_bib174","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209628","article-title":"In vitro and in vivo identification of clinically approved drugs that modify ACE 2 expression","volume":"16","author":"Sinha","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"37","key":"10.1016\/j.cbi.2021.109738_bib175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/hr.2014.49","article-title":"Role of angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/Mas axis in the hypotensive effect of azilsartan","volume":"377","author":"Iwanami","year":"2014","journal-title":"Hypertens. Res. 2014"},{"key":"10.1016\/j.cbi.2021.109738_bib176","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yjmcc.2016.05.012","article-title":"The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1\u20137)-Mas axes in pressure overload-induced cardiac remodeling in male mice","volume":"97","author":"Wang","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2021.109738_bib177","series-title":"Olmesartan Medoxomil Treatment Potently Improves Cardiac Myosin-Induced Dilated Cardiomyopathy via the Modulation of ACE-2 and ANG 1\u20137 Mas Receptor","first-page":"850","author":"Sukumaran","year":"2012"},{"key":"10.1016\/j.cbi.2021.109738_bib178","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1096\/fj.202000782","article-title":"Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: a double-edged sword?","volume":"34","author":"Yan","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2021.109738_bib179","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2021.109738_bib180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin II receptor blockers and ACE (Angiotensin-Converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.cbi.2021.109738_bib181","first-page":"883","article-title":"Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study","volume":"164","author":"Yahyavi","year":"2020","journal-title":"Intern. Emerg. Med. 2020"},{"key":"10.1016\/j.cbi.2021.109738_bib182","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151418","article-title":"In-hospital use of ACE inhibitors\/angiotensin receptor blockers associates with COVID-19 outcomes in African American patients","volume":"131","author":"Li","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2021.109738_bib183","doi-asserted-by":"crossref","first-page":"173899","DOI":"10.1016\/j.ejphar.2021.173899","article-title":"Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: a pathway-based analytical study","volume":"896","author":"Parit","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109738_bib184","article-title":"Association of renin\u2013angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study","author":"Soler","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.cbi.2021.109738_bib185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.dsx.2020.03.016","article-title":"Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.cbi.2021.109738_bib186","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib187","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2021.109738_bib188","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.01186.2004","article-title":"Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure","volume":"289","author":"Karram","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cbi.2021.109738_bib189","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"22","key":"10.1016\/j.cbi.2021.109738_bib190","first-page":"1","article-title":"Outcomes in patients with COVID-19 infection taking ACEI\/ARB","volume":"225","author":"Rico-Mesa","year":"2020","journal-title":"Curr. Cardiol. Reports 2020"},{"key":"10.1016\/j.cbi.2021.109738_bib191","series-title":"Renin-angiotensin System Inhibitors Improve the Clinical Outcomes of COVID-19 Patients with Hypertension","author":"Meng","year":"2020"},{"key":"10.1016\/j.cbi.2021.109738_bib192","series-title":"Renin\u2013Angiotensin\u2013Aldosterone System Inhibitors and Risk of Covid-19","first-page":"2441","author":"Reynolds","year":"2020"},{"key":"10.1016\/j.cbi.2021.109738_bib193","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcrc.2020.07.003","article-title":"The characteristics and outcomes of 681 severe cases with COVID-19 in China","volume":"60","author":"fang Chen","year":"2020","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.cbi.2021.109738_bib194","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/CM9.0000000000001479","article-title":"Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension","volume":"134","author":"Peng","year":"2021","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.cbi.2021.109738_bib195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000515232","article-title":"Outcomes of hospitalized COVID-19 patients receiving renin angiotensin system blockers and calcium channel blockers","volume":"52","author":"Choksi","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cbi.2021.109738_bib196","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cbi.2021.109738_bib197","first-page":"547","article-title":"OR beta-blockers therapy increase the risk OF mortality IN COVID 19 patients? The results OF a tertiary center IN Turkey","volume":"37","author":"Age","year":"2021","journal-title":"Hypertens. Coron. ARTERY Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib198","series-title":"Position Statement of the ESC Council","year":"2020"},{"key":"10.1016\/j.cbi.2021.109738_bib199","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: should inhibitors of the renin\u2013angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2021.109738_bib200","first-page":"1145","article-title":"To do or not to do: angiotensin converting enzyme inhibitors\/angiotensin receptor blocker in COVID-19 elderly patients","volume":"20","author":"Vura","year":"2021","journal-title":"EXCLI J"},{"key":"10.1016\/j.cbi.2021.109738_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2021.02.004","article-title":"Inpatient omission of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers is associated with morbidity and mortality in coronavirus disease 2019","volume":"43","author":"Oddy","year":"2021","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.cbi.2021.109738_bib202","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","volume":"5","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cbi.2021.109738_bib203","first-page":"226","article-title":"Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) are protective against ICU admission and mortality for patients with COVID-19 disease","author":"ElAbd","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib204","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fcvm.2020.00071","article-title":"COVID and the renin-angiotensin system: are hypertension or its treatments Deleterious?","author":"Zores","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cbi.2021.109738_bib205","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1152\/japplphysiol.00840.2009","article-title":"Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure","volume":"108","author":"Kar","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.cbi.2021.109738_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2020.07.006","article-title":"Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): a preliminary report","author":"Henry","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.cbi.2021.109738_bib207","first-page":"7","article-title":"Coronavirus disease 2019 (COVID\u201019) is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1","author":"Henry","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cbi.2021.109738_bib208","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biochi.2020.05.012","article-title":"SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention","volume":"175","author":"Mahmoud","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.cbi.2021.109738_bib209","article-title":"A novel purification procedure for active recombinant human DPP4 and the inability of DPP4 to bind SARS-CoV-2","author":"Xi","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.cbi.2021.109738_bib210","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6491738","article-title":"Middle east respiratory syndrome coronavirus (mers-cov): infection, immunological response, and vaccine development","volume":"2019","author":"Mubarak","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cbi.2021.109738_bib211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076469","article-title":"Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation","volume":"8","author":"Qian","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2021.109738_bib212","doi-asserted-by":"crossref","first-page":"12552","DOI":"10.1128\/JVI.01890-13","article-title":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2","volume":"87","author":"Shirato","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.cbi.2021.109738_bib213","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.cbi.2021.109738_bib214","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.00128-13","article-title":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can Be activated by TMPRSS2, and is targeted by neutralizing antibodies","volume":"87","author":"Gierer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.cbi.2021.109738_bib215","article-title":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor","volume":"5","author":"Lu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2021.109738_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110230","article-title":"Advances in the relationship between coronavirus infection and cardiovascular diseases","volume":"127","author":"Zhao","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2021.109738_bib217","article-title":"Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies","author":"Pathangey","year":"2020","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.cbi.2021.109738_bib218","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cbi.2021.109738_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30319-3","article-title":"COVID-19 outbreak and decreased hospitalisation of pregnant women in labour","author":"Kumari","year":"2020","journal-title":"Lancet Glob. Heal."},{"key":"10.1016\/j.cbi.2021.109738_bib220","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-015-0104-6","article-title":"Changes in cardiac arrest patients' temperature management after the 2013 \u201cTTM\u201d trial: results from an international survey","volume":"6","author":"Deye","year":"2016","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.cbi.2021.109738_bib221","first-page":"1","article-title":"European society of cardiology, ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2021.109738_bib222","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.0852","article-title":"Heart and lung aquaporins play a major role in severity of heart failure with preserved ejection fraction in mice and differs between comorbidities","volume":"41","author":"Villalba-Orero","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2021.109738_bib223","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13506129.2019.1625322","article-title":"Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders","volume":"26","author":"L\u00f3pez-Sainz","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.cbi.2021.109738_bib224","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biochi.2020.07.001","article-title":"High prevalence for obesity in severe COVID-19: possible links and perspectives towards patient stratification","volume":"179","author":"Dugail","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.cbi.2021.109738_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2020.03.026","article-title":"Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019","author":"Sanchis-Gomar","year":"2020","journal-title":"Mayo Clin. Proc."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721003768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721003768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:09:09Z","timestamp":1757858949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279721003768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":224,"alternative-id":["S0009279721003768"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109738","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin\u2013angiotensin-aldosterone system (RAAS) dysregulation","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109738"}}